The purpose of this investigation was to develop a rating scale that would be appropriate to use with people who are in early and middle stages of Parkinson's disease. Patients in these stages of the disease are still able to walk independently, to carry out most activities of daily living without assist, and generally to live independently. Most available rating scales are not specific for early and mid-stage disease, but rather are used across all stages of the disease, including patients who are totally dependent. Often they are not sensitive to particular changes in the earlier stages. The Duke University Parkinson's Disease Rating Scale (DUPRS) is a 22 item scale, with four gradations for each item (from not impaired to most impaired). The DUPRS is divided into three subscales (symptoms of the disease, physical performance, and psychological/cognitive symptoms). To determine whether the scale could be used by different professionals, a videotaped interview with 5 patients was scored by 16 raters from 4 different professions (geriatricians, neurologists, physical therapists, and nurses). Results demonstrated no difference in ability to rate the material by the different professionals. To determine whether different raters could elicit the same information, two raters (a geriatrician and a physical therapist) independently rated 38 subjects. Results indicated that different raters can elicit the same information. To determine whether the DUPRS subscales were valid measures of the intended information, the ratings of each subject on the three subscales were compared to ratings of subjects on established scales. Results indicated good agreement with information obtained from other established scales. In summary, a rating scale has been developed that is useful across professionals, that can be used reproducibly by different ratings, and that measures the intended information. Further testing of this scale will be performed. We will determine its sensitivity for identifying changes with progression of disease as well as improvements with specific interventions.

Project Start
Project End
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
37
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
Srinivasan, Lakshmi; Page, Grier; Kirpalani, Haresh et al. (2017) Genome-wide association study of sepsis in extremely premature infants. Arch Dis Child Fetal Neonatal Ed 102:F439-F445
Denson, Lee A; McDonald, Scott A; Das, Abhik et al. (2017) Early Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants. Am J Perinatol 34:240-247
James, Jennifer; Munson, David; DeMauro, Sara B et al. (2017) Outcomes of Preterm Infants following Discussions about Withdrawal or Withholding of Life Support. J Pediatr 190:118-123.e4
Younge, Noelle; Goldstein, Ricki F; Bann, Carla M et al. (2017) Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 376:617-628
Archer, Stephanie Wilson; Carlo, Waldemar A; Truog, William E et al. (2016) Improving publication rates in a collaborative clinical trials research network. Semin Perinatol 40:410-417
Ahmed, Zuhayer; Prasad, Indrajit; Rahman, Hafizur et al. (2016) A Male with Extreme Subcutaneous Insulin Resistance: A Case Report. Rom J Diabetes Nutr Metab Dis 23:209-213
Phelps, Dale L; Ward, Robert M; Williams, Rick L et al. (2016) Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. Pediatr Res 80:209-17
Stafford-Smith, Mark; Li, Yi-Ju; Mathew, Joseph P et al. (2015) Genome-wide association study of acute kidney injury after coronary bypass graft surgery identifies susceptibility loci. Kidney Int 88:823-32
Paine, Nicola J; Watkins, Lana L; Blumenthal, James A et al. (2015) Association of depressive and anxiety symptoms with 24-hour urinary catecholamines in individuals with untreated high blood pressure. Psychosom Med 77:136-44

Showing the most recent 10 out of 128 publications